Level Four Advisory Services’s Galera Therapeutics, Inc. Common Stock GRTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-26,441
Closed -$3.85K 919
2024
Q1
$3.85K Hold
26,441
﹤0.01% 772
2023
Q4
$3.85K Hold
26,441
﹤0.01% 769
2023
Q3
$4.63K Buy
+26,441
New +$32.9K ﹤0.01% 746

Other funds holding GRTX

Level Four Advisory Services's GRTX Position: Q2 2024 in Review

Level Four Advisory Services sold out of Galera Therapeutics, Inc. Common Stock (GRTX) in Q2 2024, closing a stake of 26,441 shares — an estimated $3.85K sold.

Level Four Advisory Services first reported a position in GRTX in Q3 2023 and held it in 3 quarters. The position peaked at $4.63K in Q3 2023. 1 fund tracked by Wall St. Rank holds GRTX as of Q2 2024.

  • Level Four Advisory Services reported no remaining Galera Therapeutics, Inc. Common Stock position as of Q2 2024 after selling out during the quarter.
  • Level Four Advisory Services sold 26,441 Galera Therapeutics, Inc. Common Stock shares in Q2 2024, an estimated $3.85K.
  • Level Four Advisory Services first reported a position in Galera Therapeutics, Inc. Common Stock in Q3 2023 and held it in 3 quarters.
  • Level Four Advisory Services's Galera Therapeutics, Inc. Common Stock position peaked at $4.63K in Q3 2023.
  • 1 fund tracked by Wall St. Rank held Galera Therapeutics, Inc. Common Stock as of Q2 2024.

Based on Level Four Advisory Services's 13F filing for Q2 2024, filed 9 Aug 2024.